US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 1.850
  • -0.010-0.54%
Close Nov 4 16:00 ET
  • 1.920
  • +0.070+3.78%
Post 18:41 ET
30.05MMarket Cap-1594P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.64%4.12M
50.81%4.38M
20.55%14.58M
56.86%5.11M
-12.05%3.11M
31.47%3.45M
8.72%2.9M
-5.63%12.09M
24.11%3.26M
-23.71%3.54M
Selling and administrative expenses
34.37%2.3M
49.57%2.82M
16.29%8.53M
73.53%3.17M
-9.46%1.77M
0.00%1.71M
1.95%1.89M
-31.95%7.34M
-4.34%1.83M
-44.51%1.95M
-General and administrative expense
34.37%2.3M
49.57%2.82M
16.29%8.53M
73.53%3.17M
-9.46%1.77M
0.00%1.71M
1.95%1.89M
-31.95%7.34M
-4.34%1.83M
-44.51%1.95M
Research and development costs
5.14%1.83M
53.12%1.56M
27.12%6.04M
35.60%1.94M
-15.21%1.35M
90.46%1.74M
24.02%1.02M
134.18%4.75M
100.03%1.43M
41.18%1.59M
Operating profit
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.63%-12.09M
-24.11%-3.26M
23.71%-3.54M
Net non-operating interest income expense
Other net income (expense)
Income before tax
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
Income tax
Net income
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
Net income continuous Operations
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
Minority interest income
Net income attributable to the parent company
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
Basic earnings per share
7.14%-0.26
-12.00%-0.28
-2.68%-1.15
-35.71%-0.38
25.00%-0.24
-7.69%-0.28
3.85%-0.25
24.83%-1.12
-27.27%-0.28
30.43%-0.32
Diluted earnings per share
7.14%-0.26
-12.00%-0.28
-2.68%-1.15
-35.71%-0.38
25.00%-0.24
-7.69%-0.28
3.85%-0.25
24.83%-1.12
-27.27%-0.28
30.43%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.64%4.12M50.81%4.38M20.55%14.58M56.86%5.11M-12.05%3.11M31.47%3.45M8.72%2.9M-5.63%12.09M24.11%3.26M-23.71%3.54M
Selling and administrative expenses 34.37%2.3M49.57%2.82M16.29%8.53M73.53%3.17M-9.46%1.77M0.00%1.71M1.95%1.89M-31.95%7.34M-4.34%1.83M-44.51%1.95M
-General and administrative expense 34.37%2.3M49.57%2.82M16.29%8.53M73.53%3.17M-9.46%1.77M0.00%1.71M1.95%1.89M-31.95%7.34M-4.34%1.83M-44.51%1.95M
Research and development costs 5.14%1.83M53.12%1.56M27.12%6.04M35.60%1.94M-15.21%1.35M90.46%1.74M24.02%1.02M134.18%4.75M100.03%1.43M41.18%1.59M
Operating profit -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.63%-12.09M-24.11%-3.26M23.71%-3.54M
Net non-operating interest income expense
Other net income (expense)
Income before tax -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M
Income tax
Net income -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M
Net income continuous Operations -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M
Minority interest income
Net income attributable to the parent company -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M
Basic earnings per share 7.14%-0.26-12.00%-0.28-2.68%-1.15-35.71%-0.3825.00%-0.24-7.69%-0.283.85%-0.2524.83%-1.12-27.27%-0.2830.43%-0.32
Diluted earnings per share 7.14%-0.26-12.00%-0.28-2.68%-1.15-35.71%-0.3825.00%-0.24-7.69%-0.283.85%-0.2524.83%-1.12-27.27%-0.2830.43%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data